MOE Workshop Series

North America

Philadelphia Area
August 03, 2017

Location: Sheraton Valley Forge
480 North Gulph Road, King of Prussia, PA, 19406, United States
MAP
Complimentary continental breakfast and lunch will be provided.

Registration

Title:
First Name: *
Last Name: *
Email: *
Job Title:
Organization: *
Business Type: *
Supervisor (academia only):
Country: *
Address: *
City: *
State/Province:
ZIP/Postal Code:
Phone: *

Comments:
  I would like to use my own laptop during the workshop(s).
  I would like to have access to the MOE scientific software before the workshop(s).

* required field

Please check the session(s) that you would like to attend:

08:30 to 09:00 Morning Coffee
09:00 to 12:30 Fragment-Based Drug Design
12:30 to 13:30 Lunch
13:30 to 17:00 Antibody Modeling and Protein Engineering in MOE

Your registration will be confirmed.



 Fragment-Based Drug Design
The course will focus on fragment-based drug design tools in MOE. Combinatorial fragment design and scaffold replacement in the receptor active site will be covered in detail, along with approaches for fragment linking and growing. A method for generating a series of closely related derivatives through medicinal chemistry transformations and the reaction based combinatorial builder will be presented. The use of pharmacophores and 2D/3D descriptors to guide drug design processes will also be discussed.

 Antibody Modeling and Protein Engineering in MOE
The course covers approaches for structure-based antibody design and includes protein-protein interactions analysis, in silico protein engineering, affinity modeling and antibody homology modeling. The interaction of a co-crystallized antibody-antigen complex will be studied by generating and examining the molecular surfaces and visualizing protein-protein interactions in 3D and 2D. Antibody properties will be evaluated using specialized calculated protein property descriptors and analyzing protein patches. The application of protein engineering tools for homology modeling and conducting property optimization of antibodies in the context of developability will be studied. Antibody optimization examples will include identification of glycosylation sites and analysis of correlated pairs using a specialized antibody database. An approach for humanizing antibody homology models will be discussed. All the steps necessary for producing and assessing antibody homology models will be described.


For questions, please contact:
Raul Alvarez
Senior Marketing Manager